Fresenius' 3Q Results Consistent With Pre-Released Figures; Maintaining EUR 81 FVE
Narrow-moat Fresenius Medical Care released full third-quarter results that were largely in line with its preliminary announcement on Oct. 16. While there are many moving parts in management's adjusted guidance for the year, our expectations were largely in agreement with this updated outlook, and we don't plan any meaningful changes to our EUR 81 fair value estimate ($48 for the ADRs). With the market implying a valuation of roughly 14 times our 2019 adjusted earnings estimate and shares curren...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.